To participate, visit ClinicalTrials.gov for registration! Sponsor: National University Hospital Research Aims The aims of this study are to determine the safety and efficacy of Neuroaid II (MLC901), in combination with standard treatment (cholinesterase inhibitors or memantine), in patients with mild to moderate Alzheimer’s disease. NeuroAid is a mixture of

To participate, visit ClinicalTrials.gov for registration! Sponsor: Axovant Sciences Ltd Research Aims The aims were to evaluate the efficacy of intepirdine (RVT-101) in combination with donepezil, compared to placebo, in patients with mild to moderate Alzheimer’s disease. How the Core Was Integral to the Study Recruited (14 patients in 6